Brant Biehn | SVP, Business Operations |
Cezar Floroiu | CEO, President & Director |
Sean Tucker | SVP & Chief Scientific Officer |
James Cummings | Chief Medical Officer |
Pete Stavropoulos | Cantor Fitzgerald |
Sahil Kazmi | B. Riley Securities FBR |
Greetings, and welcome to the Vaxart's Third Quarter 2022 Business Update and Financial Results Conference Call. A question-and-answer session will follow management's opening remarks. [Operator Instructions].
As a reminder, this conference is being recorded. I would now like to turn the webcast over to your host, Brant Biehn, Senior Vice President, Business Operations.